Development of a monoclonal antibody-based competitive enzyme-linked immunosorbent assay for detection of antibodies against duck adenovirus 3.

Publisher: BioMed Central Country of Publication: England NLM ID: 101249759 Publication Model: Electronic Cited Medium: Internet ISSN: 1746-6148 (Electronic) Linking ISSN: 17466148 NLM ISO Abbreviation: BMC Vet Res Subsets: MEDLINE

Original Publication: London : BioMed Central, 2005-

Ducks*/virology ; Antibodies, Monoclonal*/immunology ; Antibodies, Viral*/blood ; Poultry Diseases*/diagnosis ; Poultry Diseases*/virology ; Poultry Diseases*/immunology ; Adenoviridae Infections*/veterinary ; Adenoviridae Infections*/diagnosis ; Adenoviridae Infections*/virology ; Aviadenovirus*/immunology; Animals ; Enzyme-Linked Immunosorbent Assay/veterinary ; Enzyme-Linked Immunosorbent Assay/methods ; Sensitivity and Specificity ; Mice, Inbred BALB C

Competing Interests: Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Background: Duck adenovirus 3 (DAdV-3), the emerging pathogen of a disease characterized by swelling and hemorrhage in liver and kidney, is widely distributed in China, resulting in serious economic losses to the duck farms. However, no vaccine is commercially available for the prevention of the disease. Thus, a precise and reliable diagnosis is of great value for the implementation of control measure to limit the spread of DAdV-3 infection. In this study, a competitive enzyme-linked immunosorbent assay (c-ELISA) was developed for detection of antibodies against DAdV-3.
Results: In the c-ELISA, a monoclonal antibody (mAb) 3D9, which was specific to Fiber-2 protein of DAdV-3, was labeled with horseradish peroxidase (HRP) and then used as secondary antibody. The cut-off value of the c-ELISA was determined as 18% using 48 clinical negative duck sera. The preliminary concordance evaluation based on 24 duck sera revealed that the results of the c-ELISA were highly consistent with those of indirect immunofluorescence assay (IFA). The cross-reactivity assessment showed that the c-ELISA only reacted with the positive sera against DAdV-3, but not with positive sera against other duck-associated viruses tested. The coefficients of variation of intra-batch and inter-batch assays were all below 10%, suggesting a good repeatability of the c-ELISA. Moreover, 133 duck sera from animal experiments in our laboratory were detected by c-ELISA and indirect ELISA. The results showed that the coincidence rate between the two assays was 90.98% (121/133) and the Kappa value was 0.815, revealing almost perfect agreement of the two assays.
Conclusions: In summary, the c-ELISA developed here was specific, repeatable and reliable. The minimal cross-reactivity and independence of species-specific enzyme-conjugated secondary antibody made the c-ELISA a promising tool for the clinical diagnosis, serological epidemiological investigation, and evaluation of vaccine immunogenicity to control the disease caused by the infection of DAdV-3.
(© 2025. The Author(s).)

Front Cell Infect Microbiol. 2023 Mar 28;13:1177866. (PMID: 37065194)
J Virol Methods. 2018 Nov;261:86-90. (PMID: 30114433)
J Invest Dermatol. 2013 Sep;133(9):e12. (PMID: 23949770)
Virology. 2019 Jan 2;526:99-104. (PMID: 30388631)
Avian Pathol. 2022 Apr;51(2):171-180. (PMID: 35088627)
Poult Sci. 2022 Jan;101(1):101564. (PMID: 34823175)
J Virol. 2020 Aug 17;94(17):. (PMID: 32611755)
J Virol Methods. 2015 Nov;224:73-6. (PMID: 26320577)
Poult Sci. 2013 Aug;92(8):2034-43. (PMID: 23873550)
Virology. 2016 Jun;493:12-21. (PMID: 26989945)
BMC Vet Res. 2021 Feb 2;17(1):64. (PMID: 33531001)
Transbound Emerg Dis. 2022 Sep;69(5):2769-2778. (PMID: 34921519)
J Virol Methods. 2006 Sep;136(1-2):71-7. (PMID: 16730382)
J Virol Methods. 2023 Jan;311:114643. (PMID: 36332715)
Arch Virol. 2019 Mar;164(3):847-851. (PMID: 30564896)
Poult Sci. 2023 Jan;102(1):102326. (PMID: 36442305)
J Vet Sci. 2009 Dec;10(4):323-9. (PMID: 19934598)
Mol Cell Probes. 2019 Dec;48:101447. (PMID: 31518643)
Arch Virol. 2022 Sep;167(9):1879-1883. (PMID: 35729280)
AMB Express. 2023 Jun 22;13(1):62. (PMID: 37347456)

SJCX22_1807 Postgraduate Research & Practice Innovation Program of Jiangsu Province; 26116120 Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agrifood Safety and Quality

Keywords: Cross-reactivity assessment; DAdV-3; Detection of antibodies; Diagnostics; Preliminary concordance evaluation; c-ELISA

0 (Antibodies, Monoclonal)
0 (Antibodies, Viral)

Date Created: 20250329 Date Completed: 20250515 Latest Revision: 20250515

20250515

PMC11951781

10.1186/s12917-025-04661-8

40156007